BlackRock’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47M Buy
2,939,956
+277,894
+10% +$4.45M ﹤0.01% 2452
2025
Q1
$51.7M Buy
2,662,062
+598,551
+29% +$11.6M ﹤0.01% 2338
2024
Q4
$45.5M Buy
2,063,511
+342,215
+20% +$7.54M ﹤0.01% 2465
2024
Q3
$29M Sell
1,721,296
-170,313
-9% -$2.87M ﹤0.01% 2764
2024
Q2
$22.6M Buy
1,891,609
+413,885
+28% +$4.95M ﹤0.01% 2866
2024
Q1
$16.4M Buy
1,477,724
+361,163
+32% +$4M ﹤0.01% 3047
2023
Q4
$9.67M Buy
1,116,561
+433,616
+63% +$3.76M ﹤0.01% 3344
2023
Q3
$5.22M Buy
682,945
+206,103
+43% +$1.58M ﹤0.01% 3589
2023
Q2
$3.43M Sell
476,842
-3,175
-0.7% -$22.9K ﹤0.01% 3778
2023
Q1
$2.92M Buy
480,017
+146,057
+44% +$889K ﹤0.01% 3795
2022
Q4
$1.46M Sell
333,960
-88,640
-21% -$386K ﹤0.01% 4190
2022
Q3
$1.66M Buy
422,600
+211
+0% +$827 ﹤0.01% 4198
2022
Q2
$2.15M Sell
422,389
-15,136
-3% -$77.2K ﹤0.01% 4142
2022
Q1
$2.8M Buy
437,525
+217
+0% +$1.39K ﹤0.01% 4165
2021
Q4
$3.51M Buy
+437,308
New +$3.51M ﹤0.01% 4085